Best Life Sciences Tech Companies in Seattle, United States
The 39 best Life Sciences Tech companies in Seattle, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Truveta.
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Seattle
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Truveta 🦄 Provider of healthcare data platform for learning services | $200M | 19 mo ago | 250 250 → 443 (+77%) | Jay Nanduri Co-Founder & CTO | WordPressApple iCloud MailMicrosoft 365+45 | Top 5M | 17 patents Privacy-preserving health data integration, normalization, and analytics using de‑identification and ontology matching | — |
| 2 | Aahi Digital vaccine development tools and services | $100M | 95 mo ago | 60 | Corey Casper President and Chief Executive Officer | WordPressMySQLPHP+18 | Top 50M | — | — |
| 3 | Ozette Developer of computational drug discovery platform | $32M | 49 mo ago | 12 12 → 29 (+142%) | Raphael Gottardo Co-Founder | — | — | — | — |
| 4 | Cyrus Biotechnology Developer of cloud-based protein-modelling software for drug discovery | $32M | 20 mo ago | 23 23 → 17 (-26%) | — | — | — | — | — |
| 5 | Curi Bio Manufacturer of drugs for multiple therapautic areas 60Funding top 25%Growth top 28%Tech top 33%Talent bottom 49% All 8 signals ▾Fundingtop 25% Growthtop 28% Techtop 33% Talentbottom 49% Newsbottom 42% Marketbottom 40% Moatbottom 38% Globalbottom 37% Funding: Raised $21.0M across 13 rounds · 13 rounds over 5 yrs (2.6/yr) Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 60/100 | $21M | 9 mo ago | 47 47 → 57 (+21%) | Nicholas Geisse CEO | Cart FunctionalitySquarespace CommerceSquarespace+32 | Top 5M | — | — |
| 6 | Archon Bio Provider of computational platform to develop protein therapeutics | $20M | 22 mo ago | — | George Ueda Co-Founder & CTO | Cart FunctionalitySquarespace CommerceSquarespace+23 | Top 10M | — | — |
| 7 | Talus Provider of drug discovery platform for gene regulators | $20M | 17 mo ago | 15 | Alex Federation Co-Founder & CEO | WordPressMySQLPHP+23 | Top 10M | 27 patents Automotive interior storage and organization systems for floor and cargo compartments | — |
| 8 | Accipiter Biosciences Developer of de novo protein therapies for complex diseases treatment | $13M | 10 mo ago | — | Javier Castellanos Co-Founder & CTO | WordPressMySQLPHP+14 | Top 50M | — | — |
| 9 | Synthesize Bio Provider of AI-generated gene expression data for biological research purposes | $10M | 11 mo ago | — | Robert Bradley Co-Founder | WebflowApple iCloud MailGSAP+13 | Top 50M | — | 1 launch |
| 10 | Appature Appature offers cloud-based marketing and Software-as-a-Service (SaaS) solutions to the healthcare and pharma… | $10M | 169 mo ago | 60 | — | — | — | 9 patents Data-driven healthcare marketing analytics and optimization platforms | — |
| 11 | Author-it Software CCMS solutions for collaborative content, documentation, eLearning, and policy management | $9M | 122 mo ago | 49 | — | WordPressApple iCloud MailMicrosoft 365+34 | Top 10M | — | — |
| 12 | Pathware Developer of cloud-based imaging and sample management platform | $8M | 38 mo ago | 13 | Jaron Nix Co-Founder & CTO | — | — | 15 patents Automated computational microscopy for point-of-care pathology imaging and analysis | — |
| 13 | Genemod Provider of cloud-based laboratory management software for research labs | $7M | 40 mo ago | 16 | Jin Choe Co-Founder & CTO | Cart FunctionalityApple iCloud MailMicrosoft 365+16 | Top 10M | — | 1 launch · 1 award |
| 14 | Alpenglow Biosciences Provider of software for 3D visualization of images | $6M | 30 mo ago | 27 | Nicholas Reder CEO | Cart FunctionalitySquarespace CommerceSquarespace+19 | Top 50M | — | — |
| 15 | Potato Developer of an AI platform for life science research execution | $6M | 17 mo ago | — | Ryan Kosai Co-Founder & CTO | Amazon Web ServicesCloudflareUnpkg+14 | Top 50M | — | — |
| 16 | Geospiza Develops enterprise software systems for workflow management of genetic analysis | $5M | 188 mo ago | 1 | — | — | — | — | — |
| 17 | Neoleukin Therapeutics Manufacturers of therapeutic proteins to treat immunological disorders | $5M | 186 mo ago | 7 | Jonathan Drachman CEO & President | — | — | — | — |
| 18 | Insilicos Proteomic analysis software solutions | $4M | 180 mo ago | — | Brian Pratt Co-Founder | — | — | 9 patents Patents concentrated in computing, sensing & instrumentation | — |
| 19 | ZipBio Developer of AI-driven platform creating de novo genes and protein therapeutics | $4M | 24 mo ago | — | Roee Farber Co-Founder & CEO | WixSentryUIKit+12 | Top 50M | — | — |
| 20 | Spiral Genetics Provider of software to analyze next generation sequencing data | $4M | 89 mo ago | 8 | — | AMPCloudflareOpen Graph+1 | Top 5M | 30 patents Efficient compressed data indexing using prefix BWT and cloud-based sorting algorithms | — |
| 21 | Kuleon Drug discovery company that utilizes AI-based technology to identify novel serotonergic drugs for targeted… | $1M | 13 mo ago | 5 | David Gilles Co-Founder and CTO | — | — | 37 patents Design and synthesis of heterocyclic serotonin receptor ligands for CNS disorder therapies | — |
| 22 | Glencoe Software Imaging solutions for digital pathology and publishing sectors | $800K | 138 mo ago | 12 | — | ZURB FoundationVideoJSAmazon Web Services+10 | Top 50M | — | — |
| 23 | Corengi Platform for clinical trial discovery and recruitment | $490K | 165 mo ago | 1 | — | — | — | — | — |
Top 12 Life Sciences Tech companies in Seattle
#1
Series B · Seattle, Washington · founded 2015 · 47 employees$21Mraised▾
Manufacturer of drugs for multiple therapautic areas
- Dec 2025Series B$10M
- Feb 2025Grant (prize money)$2.3M
- Jan 2025Grant (prize money)$2.1M
- Dec 2023Grant (prize money)$2.3M
#2
Truveta 🦄Series C · Seattle, Washington · founded 2020 · 250 employees$200Mraised▾
Provider of healthcare data platform for learning services
- Jan 2025Series C$320M
- Nov 2021Series B$100M
- Sep 2021Series A—
- Jul 2021Series A$95M
#3
Seed · Seattle, Washington · founded 2023$12.7Mraised▾
Developer of de novo protein therapies for complex diseases treatment. These single-agent biologics are custom-engineered to engage multiple pathways. The biologics combine multiple mechanisms in one stable protein molecule. Therapeutic candidates activate more than one cell-surface receptor on the same cell. The platform uses computational methods to create customizable, multifunctional proteins. The company advances a pipeline in autoimmunity and oncology.
- Nov 2025Seed$12.7M
#4
Series A · Seattle, Washington · founded 2023$10Mraised▾
Provider of AI-generated gene expression data for biological research purposes. The company offers a platform enabling scientists to generate and analyze genomic data. It allows users to customize AI models, combine AI and experimental data, and visualize expression data. The platform supports molecular experiment design, synthetic control generation, and rare sample augmentation. It also facilitates data analysis, collaboration, and access to preprocessed public data.
- Sep 2025Series A$10M
#5
Seed · Seattle, Washington · founded 2020 · 15 employees$19.8Mraised▾
Provider of drug discovery platform for gene regulators. The company provides a functional proteomics platform MARMOT focused on studying full-length GRPs in an unmodified cellular environment. It allows the development of therapeutics against the disease-causing GRPs.
- Apr 2025Grant (prize money)$398.4K
- Feb 2025Grant (prize money)$2M
- Jul 2024Seed$11.2M
- Aug 2023Grant (prize money)$4.3M
#6
Series B · Seattle, Washington · founded 2014 · 23 employees$32Mraised▾
Developer of cloud-based protein-modeling software for drug discovery. Their lead product, Cyrus Bench is a modified version of the open-source Rosetta molecular modeling software. Cyrus Bench delivers Rosetta with the complete associated array of bio-molecular computation tools (e.g. BLAST) required to use Rosetta to its full potential, along with a custom UI.
- Dec 2024Grant (prize money)$300K
- Sep 2024Grant (prize money)$298.9K
- Feb 2024Series B$2.7M
- Dec 2021Series B$18.4M
#7
Seed · Seattle, Washington · founded 2023$20Mraised▾
Provider of computational platform to develop protein therapeutics. It combines antibodies with AI-generated proteins and Antibody Cage that leverages geometric engineering to control biodistribution and engagement to develop therapeutic targets.
- Oct 2024Seed$20M
#8
Series A · Seattle, Washington · founded 2023$5.5Mraised▾
Developer of an AI platform for life science research execution. The platform supports literature search, scientific tool utilization, and collaboration with an AI co-scientist. It facilitates end-to-end experiment execution for research and development teams. The platform translates scientific intent into reproducible workflows, delivering protocols and robot-ready scripts. It also analyzes raw results and generates reports for iterative experimentation.
- Apr 2025Series A$4.5M
- Oct 2024Seed$1M
#9
Funding Raised · Seattle, Washington · founded 2021 · 5 employees$1Mraised▾
Drug discovery company that utilizes AI-based technology to identify novel serotonergic drugs for targeted treatments. It offers a portfolio of serotonin receptor ligands that target neurocircuit abnormalities in the brain that are responsible to-treat disorders such as schizophrenia and depression.
- Jul 2025Grant (prize money)$1M
#10
Series A · Seattle, Washington · founded 2014 · 27 employees$6.4Mraised▾
Provider of software for 3D visualization of images. The company provides AI-assisted software for researchers to analyze images of complex & morphological structures of tissue samples.
- Mar 2024Series A$3M
- Apr 2022Grant (prize money)$252.5K
- Sep 2021Grant (prize money)$269.3K
- Jul 2021Grant (prize money)$398.3K
#11
Seed · Seattle, Washington · founded 2023$4Mraised▾
Developer of AI-driven platform creating de novo genes and protein therapeutics. The platform aims to address unmet medical needs by designing compact, highly effective therapeutic molecules. The company focuses on developing transformative therapies for diseases affecting millions. It utilizes generative AI to distill multiple complex functions.
- Sep 2024Seed$4M
#12
Funding Raised · Seattle, Washington · founded 1993 · 60 employees$100.3Mraised▾
Digital vaccine development tools and services. The company has built a platform that assists with RNA and adjuvant formulations and the development of platforms for next-generation vaccines and immunotherapies. The company gives services for house manufacturing, formulation, product development, and more.
- Sep 2018Grant (prize money)$3.3M
- Feb 2018Grant (prize money)$1.6M
- Aug 2016Grant (prize money)$491.1K
- May 2016Grant (prize money)$6.6M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.